GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of reading state board threads from 2024 and half of it aged badly — 12 comments in the full submission. View in context.
587
c/compounding·submitted 2 years ago by u/step_therapy_s

reading state board threads from 2024 and half of it aged badly

Pricingbranch of 10 comments

shortage list. That is the whole post, but I will justify it. Everything else people worry about in c/coldchain is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort shortage list out first, and almost nobody does. I say this having got it wrong for 6 months. My…

Read the full submission and all 12 comments →

This branch

10 comments, started 2 years ago
u/milos_mensa58 points·2 years ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/step_therapy_sOP84 points·2 years ago

What is the actual shortage list status right now?

replysharereportpermalink
u/swirl_dont_shakereconstitution37 points·2 years ago·edited

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/camila_sandvik16 points·2 years ago·edited

shortage list status is shortage list, check the actual list

replysharereportpermalink
u/tobias_vukovic47 points·2 years ago·edited

shortage list status is API source, check the actual list

replysharereportpermalink
u/cold_chromatogram3111 points·2 years ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/liver_enzyme_liz11 points·2 years ago

Small correction: the trial was 18 weeks, not 33. Does not change your point but people will quote it.

replysharereportpermalink
u/rt_shift_reggie4 points·2 years ago·edited

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/niels_roos9 points·2 years ago

state board rules differ, say which state

replysharereportpermalink
u/hamza_serrano-3 points·2 years ago

API source questions are on-topic and compounders dodging them is newsworthy

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →